Gastroenterology Practice Questions

Q: Antiendomysial antibody is used in the screening of which condition?

Coeliac disease. **Explanation:** **Coeliac Disease (Correct Answer):** Anti-endomysial antibody (EMA) is a highly specific serological marker for Coeliac disease [1]. It is an IgA-class antibody directed against **tissue transglutaminase (tTG)** located in the endomysium (the connective tissue sheath surrounding muscle fibers) [1]. * **Gold Standard Screening:** While **IgA anti-tTG** is the preferred initial screening test due to its high sensitivity and lower cost, **IgA Anti-endomysial antibody** has a specificity approaching 100%, making it excellent for confirming a positive screening result before proceeding to a small bowel biopsy. **Incorrect Options:** * **Myasthenia Gravis:** Characterized by antibodies against **acetylcholine receptors (AChR)** or muscle-specific kinase (MuSK) at the neuromuscular junction. * **Autoimmune Hepatitis:** Associated with **Anti-nuclear antibodies (ANA)** and **Anti-smooth muscle antibodies (ASMA)** in Type 1, and **Anti-liver kidney microsomal-1 (LKM-1)** antibodies in Type 2 [2]. * **Graves Disease:** Caused by **Thyroid-stimulating immunoglobulin (TSI)** which acts as an agonist to the TSH receptor. **High-Yield Clinical Pearls for NEET-PG:** 1. **Total IgA levels** must be checked alongside Coeliac serology. If a patient is IgA deficient (common in Coeliac), IgA-based tests (EMA/tTG) will be falsely negative; in such cases, **IgG-based tests** (IgG-tTG or IgG-DGP) should be used. 2. **HLA Association:** Coeliac disease is strongly associated with **HLA-DQ2** (95%) and **HLA-DQ8** [1]. 3. **Biopsy Finding:** The characteristic histological feature is **villous atrophy**, crypt hyperplasia, and increased intraepithelial lymphocytes (Marsh Classification) [1]. 4. **Dermatitis Herpetiformis:** The pathognomonic skin manifestation of Coeliac disease, showing granular IgA deposits on skin biopsy.

Q: What is the most common cause of upper gastrointestinal tract bleeding?

Peptic ulcer. **Explanation:** **Peptic Ulcer Disease (PUD)** is the most common cause of upper gastrointestinal bleeding (UGIB) worldwide, accounting for approximately 40–50% of all cases [1]. This includes both gastric and duodenal ulcers. The underlying mechanism involves the erosion of the gastrointestinal mucosa by acid and pepsin, often secondary to *H. pylori* infection or the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), leading to the involvement of underlying submucosal vessels [1]. **Analysis of Incorrect Options:** * **Esophageal Varices:** While variceal bleeding is a significant cause of UGIB, especially in patients with chronic liver disease and portal hypertension, it is less common than PUD [1]. However, it is often more severe and carries a higher mortality rate. * **Gastritis:** Erosive gastritis and gastropathy (often due to alcohol or NSAIDs) are common causes of minor bleeding but occur less frequently than discrete peptic ulcers as a source of major UGIB [1]. * **Mallory-Weiss Tear:** This refers to longitudinal mucosal lacerations at the gastroesophageal junction, typically following forceful vomiting or retching. It accounts for only about 5–10% of UGIB cases. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of UGIB:** Peptic Ulcer Disease [1]. * **Most common site of PUD bleeding:** The posterior wall of the duodenal bulb (involving the **Gastroduodenal artery**). * **Rockall Score & Glasgow-Blatchford Score:** These are the clinical scoring systems used to risk-stratify patients with UGIB [1]. * **Management:** Intravenous Proton Pump Inhibitors (PPIs) and early endoscopy (within 24 hours) are the cornerstones of management.

Q: Which of the following statements about peptic ulcer disease is true?

The incidence of complications has remained unchanged.. ### Explanation **Correct Option: B. The incidence of complications has remained unchanged.** While the overall incidence of Peptic Ulcer Disease (PUD) has significantly declined due to effective *H. pylori* eradication and the widespread use of Proton Pump Inhibitors (PPIs), the incidence of **complications** (such as perforation and hemorrhage) has remained relatively stable. This is primarily attributed to the increasing use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and low-dose aspirin among the aging population, which offsets the gains made by treating *H. pylori* [1]. **Analysis of Incorrect Options:** * **Option A:** *H. pylori* eradication **decreases** the likelihood of complications. It is the most effective strategy to prevent ulcer recurrence and subsequent bleeding or perforation [1]. * **Option C:** In developing countries like India, the reinfection rate of *H. pylori* is **high** (often >2% per year) due to overcrowding, poor sanitation, and contaminated water sources, unlike the low rates (<1%) seen in developed nations. * **Option D:** *H. pylori* eradication **dramatically alters** the recurrence ratio. Without eradication, ulcer recurrence rates are 60–90%; after successful eradication, this drops to <10% [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common complication of PUD:** Upper GI Bleed (Hematemesis/Melena) [1]. * **Most common site of perforation:** Anterior wall of the duodenum [1]. * **H. pylori Association:** Strongly linked to Duodenal Ulcers (90-95%) more than Gastric Ulcers (70-80%) [1]. * **Investigation of Choice:** Upper GI Endoscopy (UGIE). * **Gold Standard for H. pylori diagnosis:** Endoscopic biopsy followed by Histopathology (though Urease Breath Test is the best non-invasive test for confirming eradication) [1].

Q: Pancreatic cholera is characterized by all except?

Hypocalcemia. Explanation: Pancreatic cholera, also known as **WDHA syndrome** (Watery Diarrhea, Hypokalemia, Achlorhydria) or **Verner-Morrison syndrome**, is caused by a **VIPoma**—a neuroendocrine tumor (usually in the pancreas) that secretes excessive Vasoactive Intestinal Peptide (VIP) [1]. **Why Hypocalcemia is the correct answer:** Pancreatic cholera is typically associated with **Hypercalcemia**, not hypocalcemia [1]. This occurs because VIP has a direct bone-resorbing effect and because VIPomas are frequently associated with **MEN-1 syndrome**, where co-existing hyperparathyroidism leads to elevated calcium levels. **Analysis of Incorrect Options:** * **Hypochlorhydria (A):** VIP inhibits gastric acid secretion by parietal cells, leading to achlorhydria or hypochlorhydria. * **Hypokalemia (B):** Massive watery diarrhea (often >3L/day) leads to significant fecal loss of potassium, resulting in profound hypokalemia and muscle weakness. * **Glucose intolerance (C):** VIP stimulates glycogenolysis in the liver and inhibits insulin secretion, leading to hyperglycemia and impaired glucose tolerance in about 50% of patients. **Clinical Pearls for NEET-PG:** * **Mnemonic (WDHA):** **W**atery **D**iarrhea, **H**ypokalemia, **A**chlorhydria. * **Stool Characteristics:** The diarrhea is "secretory" in nature (persists during fasting) and has a low osmotic gap. * **Diagnosis:** Elevated fasting plasma VIP levels (>200 pg/mL). * **Localization:** Most VIPomas are found in the **tail of the pancreas**. * **Management:** Octreotide (Somatostatin analogue) is used to control symptoms by inhibiting VIP release.

Q: All of the following are true for patients with ulcerative colitis associated with primary sclerosing cholangitis (PSC), EXCEPT:

PSC reverses after a total colectomy.. The correct answer is **D**. The underlying medical concept is that **Primary Sclerosing Cholangitis (PSC)** follows a clinical course independent of the underlying **Ulcerative Colitis (UC)** [2]. While approximately 70-80% of PSC patients have UC [3], performing a total colectomy (which is curative for the intestinal symptoms of UC) does not halt, reverse, or prevent the progression of PSC or the risk of associated biliary malignancies. **Analysis of Options:** * **Option A (Biliary Cirrhosis):** True. PSC is a chronic cholestatic disease characterized by progressive inflammation and fibrosis of the intrahepatic and extrahepatic bile ducts. This leads to "beading" on imaging and eventually results in secondary biliary cirrhosis and liver failure. * **Option B (Raised Alkaline Phosphatase):** True. A cholestatic pattern of liver enzymes is the hallmark of PSC. An elevated serum alkaline phosphatase (ALP) is often the first biochemical abnormality detected, even in asymptomatic patients [1]. * **Option C (Hilar Cholangiocarcinoma):** True. Patients with PSC have a significantly increased lifetime risk (up to 10-15%) of developing cholangiocarcinoma, most commonly at the biliary confluence (Klatskin tumor/hilar type). **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** MRCP (shows "string of beads" appearance). Liver biopsy shows pathognomonic **"onion-skin" fibrosis**. * **Antibody:** p-ANCA is positive in 60-80% of cases [1], [3]. * **Cancer Risks:** PSC increases the risk of both **Cholangiocarcinoma** and **Colorectal Cancer** (more so than UC alone). * **Treatment:** Liver transplantation is the only definitive treatment for end-stage PSC; medical therapies like Ursodeoxycholic acid (UDCA) improve biochemistry but not survival.

Q: All of the following are true of achalasia cardia, except:

Mecholyl test is hyposensitive. Achalasia cardia is a primary esophageal motility disorder characterized by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of esophageal peristalsis [2]. This occurs due to the degeneration of the inhibitory neurons (containing NO and VIP) in the **myenteric (Auerbach’s) plexus** [1][2]. **Why Option C is the correct answer (The Exception):** The **Mecholyl (Methacholine) test** is based on **Cannon’s Law of Denervation Supersensitivity**. In achalasia, the loss of ganglionic cells makes the esophageal smooth muscle **hypersensitive** to cholinergic stimulation. When a parasympathomimetic like Mecholyl is administered, it triggers a vigorous, high-amplitude contraction of the esophagus. Therefore, the test is **hypersensitive**, not hyposensitive. (Note: This test is largely historical and replaced by manometry). **Analysis of Incorrect Options:** * **A. Dysphagia:** This is the most common presenting symptom. It is characteristically paradoxical, occurring for both solids and liquids from the onset [2]. * **B. Aspiration pneumonitis:** Due to the failure of the LES to open, food and saliva pool in the dilated esophagus. Regurgitation of this undigested material, especially at night, leads to nocturnal cough and aspiration pneumonia [2]. * **D. X-ray finding:** A Barium swallow typically shows a dilated esophagus with a smooth, tapered narrowing at the distal end, described as the **"Bird’s beak"** or **"Rat-tail"** appearance [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Esophageal Manometry (shows incomplete LES relaxation and aperistalsis) [2]. * **Most common symptom:** Dysphagia. * **Most common complication:** Esophagitis; however, there is an increased risk of **Squamous Cell Carcinoma** (due to chronic stasis). * **Treatment of choice:** Heller’s Myotomy (often with Dor/Toupet fundoplication) [1] or POEM (Peroral Endoscopic Myotomy).

Q: A patient on enteral nutrition develops diarrhea. Which of the following statements is/are true?

Diarrhea seen in > 30% cases. **Explanation:** Diarrhea is the most common gastrointestinal complication of enteral nutrition (EN), occurring in **30% to 50% of patients** depending on the definition used and the clinical setting (ICU vs. ward). **Analysis of Options:** * **A (Correct):** Diarrhea is highly prevalent in patients receiving EN, with studies consistently showing rates exceeding 30%. It is often multifactorial, related to the underlying illness, medications, or the feeding process itself. * **B (Incorrect):** There is no significant clinical evidence that duodenal feeding causes more diarrhea than jejunal feeding. In fact, post-pyloric feeding (both duodenal and jejunal) is often used to bypass gastric stasis, though it does not inherently increase the risk of diarrhea compared to gastric feeding. * **C (Incorrect):** While contamination is a risk, the **most common cause** of diarrhea in these patients is actually **concurrent medication use** (especially antibiotics, prokinetics, and sorbitol-containing liquid medications) or the underlying disease process (e.g., sepsis, hypoalbuminemia) [1]. * **D (Incorrect):** While *C. difficile* is a concern in hospitalized patients, it is not the *first* or most common cause to exclude in enteral nutrition-related diarrhea [1]. The initial management focuses on reviewing medications and adjusting the delivery rate/osmolarity of the feed. **NEET-PG High-Yield Pearls:** * **Management:** Do not automatically stop enteral feeds for diarrhea. Instead, decrease the rate of infusion, review medications (especially those with high osmolarity), and ensure the feed is at room temperature. * **Fiber:** Adding soluble fiber (e.g., guar gum) can help manage diarrhea in EN patients. * **Osmolarity:** Standard enteral formulas are usually isotonic; however, hyperosmolar feeds or rapid "bolus" delivery into the small intestine (Dumping Syndrome) can trigger osmotic diarrhea.

Q: All of the following are associated with ulcerative colitis except?

Circinate balanitis. **Explanation:** The correct answer is **Circinate balanitis**. This condition is a characteristic feature of **Reactive Arthritis** (formerly Reiter’s Syndrome), not Ulcerative Colitis (UC). It presents as painless, serpiginous dermatitis on the glans penis. **Why the other options are incorrect:** Ulcerative Colitis is associated with several **Extraintestinal Manifestations (EIMs)** [1], which are frequently tested in NEET-PG: * **Erythema nodosum (Option A):** This is the most common skin manifestation of Inflammatory Bowel Disease (IBD) [1]. It typically correlates with the activity of the underlying bowel disease. * **Primary Sclerosing Cholangitis (PSC) (Option C):** This is highly specific to UC (found in ~5% of patients). Unlike other EIMs, the course of PSC is **independent** of the bowel disease activity and is not cured by colectomy. * **Aphthous stomatitis (Option D):** These painful oral ulcers are common in both UC and Crohn’s disease and often parallel the severity of intestinal inflammation. **NEET-PG High-Yield Pearls:** 1. **Skin:** Pyoderma gangrenosum is more specific to UC, while Erythema nodosum is more common [1]. 2. **Eyes:** Episcleritis and Uveitis are common EIMs [1]. 3. **Joints:** Peripheral arthritis (Type 1 and 2) and Ankylosing Spondylitis (HLA-B27 associated) [1]. 4. **Key Distinction:** EIMs that **parallel** bowel activity include Erythema nodosum, Peripheral arthritis, and Episcleritis. EIMs **independent** of bowel activity include PSC and Ankylosing Spondylitis.

Question 1

Antiendomysial antibody is used in the screening of which condition?

Accepted Answer

Coeliac disease

Answer

Myasthenia gravis

Answer

Autoimmune hepatitis

Answer

Graves disease

Question 2

What is the most common cause of upper gastrointestinal tract bleeding?

Accepted Answer

Peptic ulcer

Answer

Esophageal varices

Answer

Gastritis

Answer

Mallory-Weiss tear

Question 3

A 52-year-old alcoholic male develops chronic severe upper abdominal pain and maldigestion. Ultrasound studies demonstrate pancreatic calcifications. Which of the following disorders will this patient most likely develop?

Accepted Answer

Diabetes mellitus

Answer

Hyperthyroidism

Answer

Hypothyroidism

Answer

Pheochromocytoma

Question 4

Which of the following statements about peptic ulcer disease is true?

Accepted Answer

The incidence of complications has remained unchanged.

Answer

Helicobacter pylori eradication increases the likelihood of occurrence of complications.

Answer

The incidence of Helicobacter pylori reinfection in India is very low.

Answer

Helicobacter pylori eradication does not alter the recurrence ratio.

Question 5

Pancreatic cholera is characterized by all except?

Accepted Answer

Hypocalcemia

Answer

Hypochlorhydria

Answer

Hyokalemia

Answer

Glucose intolerance

Question 6

All of the following are true for patients with ulcerative colitis associated with primary sclerosing cholangitis (PSC), EXCEPT:

Accepted Answer

PSC reverses after a total colectomy.

Answer

They may develop biliary cirrhosis.

Answer

May have a raised alkaline phosphatase.

Answer

Increased risk of hilar cholangiocarcinoma.

Question 7

All of the following are true of achalasia cardia, except:

Accepted Answer

Mecholyl test is hyposensitive

Answer

Dysphagia

Answer

Aspiration pneumonitis

Answer

X-ray finding of dilated esophagus with a narrow end

Question 8

A patient with a known history of pancreatitis presents on Day 4 with breathlessness and basal crepitations. What is the most likely diagnosis?

Accepted Answer

Acute respiratory distress syndrome (ARDS)

Answer

Atelectasis

Answer

Pleural effusions

Answer

Aspiration pneumonia

Question 9

A patient on enteral nutrition develops diarrhea. Which of the following statements is/are true?

Accepted Answer

Diarrhea seen in > 30% cases

Answer

More diarrhea in duodenal nutrition than jejunal nutrition

Answer

Most common cause is contamination of food

Answer

In persistent diarrhea, Clostridium difficile should be excluded

Question 10

All of the following are associated with ulcerative colitis except?

Accepted Answer

Circinate balanitis

Answer

Erythema nodosum

Answer

Sclerosing cholangitis

Answer

Aphthous stomatitis

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?